# Pear Therapeutics, Inc.

- Location (FDA's records): Boston, MA
- FDA decisions: 3 (2017–2020): 2 510(k) clearances and 1 De Novo grant
- Product codes: PWE (2), QVO (1)
- Predicates its devices cite: 1 (1 its own); citations of its devices by later devices: 5 (1 its own)
- Recalls linked to its devices: 2 (0 Class I)
- Data: FDA decisions to Oct 25, 2026; recalls to Oct 12, 2026

## Firms that cite its devices most
- Big Health, Inc.: 2 (https://510kreport.com/company/big-health)
- Curio Digital Therapeutics, Inc.: 1 (https://510kreport.com/company/curio-digital-therapeutics)
- Otsuka America Pharmaceutical, Inc.: 1 (https://510kreport.com/company/otsuka-america-pharmaceutical)

## Its most-cited devices
- K191716: Somryst (2020), cited by 3
- DEN160018: reSet (2017), cited by 2

## Recent decisions
- K191716: Somryst (Mar 23, 2020)
- K173681: reSET-O (Dec 10, 2018)
- DEN160018: reSet (Sep 14, 2017)

Source page: https://510kreport.com/company/pear-therapeutics